default author photo

Prachi Schukla

affiliation not provided to SSRN

  • affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

97

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Combination of the Novel Raf Dimer Inhibitor Brimarafenib with the Mek Inhibitor Mirdametinib is Effective Against Nras Mutant Melanoma

Number of pages: 45 Posted: 09 Sep 2024
Flavia L. Tellenbach, Luzia L. Seiler, Mark Johnson, Hubert Rehrauer, Prachi Schukla, Julia Martinez-Gomez, Corinne I. Stoffel, Adeela Kamal, Reinhard Dummer, Mitchell Paul Levesque and Ossia M. Eichhoff
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Zurich, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University Hospital Zurich - Department of Dermatology, University Hospital Zurich - Department of Dermatology and affiliation not provided to SSRN
Downloads 97 (704,534)

Abstract:

Loading...

Metastatic melanomaRAF dimer inhibitorMAPK pathwaydual inhibitionNRAS mutation